Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1979-04-16
1981-01-06
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
A61K 31415
Patent
active
042436710
ABSTRACT:
1-(3-Phenyl-2-propenyl)-1H-imidazole, and its hydrochloride salt have been found to be potent inhibitor of thromboxane synthetase and therefore an inhibitor of arachidonic acid-induced platelet aggregation and bronchoconstriction.
REFERENCES:
Tai et al. Biochem. and Biophys. Res. Commun., 80: 236-242 (1978).
Yoshimoto et al. Prostaglandins, 16, No. 4, 529-540 (1978).
Nijkamp et al. Europ. J. Pharmacoc., 44; 179-186 (1977).
Chemical Abstracts 83: 157710t (1975).
Moncada et al., Prostaglandins 13, No. 4; 611-618 (1977).
Greenberg Roland
Harris Don N.
Phillips Marie B.
E. R. Squibb & Sons Inc.
Levinson Lawrence S.
Rodney Burton
Schenkman Leonard
LandOfFree
Inhibition of thromboxane synthetase formation and arachidonic a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of thromboxane synthetase formation and arachidonic a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of thromboxane synthetase formation and arachidonic a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-285099